While studies of glucose-insulin-potassium (GIK) infusion to patients undergoing cardiac surgery have shown a cardioprotective effect [131,132], GIK infusion to patients with ST-elevation myocardial infarction (STEMI) has yielded conflicting results about cardioprotective efficacy [133,134,135]. Here, INS is linked to ST Elevation Myocardial Infarction.